phase readout
saveNCT03580083: RGX-111 Gene Therapy in Patients With MPS I
SUSPENDEDupdated 1mo ago
community read0 votes
Sponsor: REGENXBIO Inc.. Phase: PHASE1. Conditions: Mucopolysaccharidosis Type I (MPS I), Hurler Syndrome, Hurler-Scheie Syndrome
view source ↗
comments(0)
5-min edit window · permanent after that